Insmed (NASDAQ:INSM) has outperformed the market over the past 10 years by 10.74% on an annualized b

Liquidia's Yutrepia is driving strong growth, but Insmed's Brinsupri and broader pipeline could make

BRIDGEWATER, N.J., Aug. 26, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first

Duquesne Family Office has beefed up its healthcare holdings.

The Alger Mid Cap 40 ETF outperformed the Russell Midcap Growth Index during the second quarter of 2

— First-in-Disease and First-in-Class Therapy Approved in Japan for Patients With Non-Cystic Fibrosi

Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the se

Biotech stocks are having one of their best stretches in years. The iShares Biotechnology ETF (NASDA

The iShares Biotechnology ETF is trading at new highs and 18 out of its top 20 constituents are gree

JP Morgan analyst Jessica Fye maintains Insmed (NASDAQ:INSM) with a Overweight and lowers the pri

Truist Securities analyst Danielle Brill reiterates Insmed (NASDAQ:INSM) with a Buy and raises th

Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 29.76% on an annualized ba

Guggenheim analyst Vamil Divan maintains Insmed (NASDAQ:INSM) with a Buy and lowers the price tar

INSM tops Q2 revenue and earnings estimates as strong Brinsupri uptake drives a 34% stock jump and p

Wells Fargo analyst Benjamin Burnett maintains Insmed (NASDAQ:INSM) with a Overweight and raises

Evercore ISI Group analyst Josh Schimmer maintains Insmed (NASDAQ:INSM) with a Outperform and rai

Insmed NASDAQ: INSM reported second-quarter 2026 revenue growth driven by the continued launch of BR

Crude's rebound on Yemen strikes pulled U.S. equities off record highs Thursday, while SanDisk p

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'

Dow drops over 300 points, NASDAQ down 0.05% and S&P 500 down 0.19%. Keurig Dr Pepper reports st

Insmed Incorporated (INSM) Q2 2026 Earnings Call Transcript

Although the revenue and EPS for Insmed (INSM) give a sense of how its business performed in the qua

US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporti

Insmed (INSM) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's

Insmed (NASDAQ:INSM) reported quarterly losses of $(0.06) per share which beat the analyst consensus

Insmed (NASDAQ:INSM) raises FY2026 sales outlook from $1.450 billion-$1.470 billion to $1.700 billio

—Total Company Revenues of $425.5 Million for the Second Quarter of 2026— —BRINSUPRI ® (brensocatib)

Bank of Nova Scotia reduced its position in Insmed, Inc. (NASDAQ: INSM) by 75.0% during the undefine

Harmony Biosciences, Acadia, Biogen, Insmed and Agios show positive Earnings ESPs ahead of Q2 result

BRIDGEWATER, N.J., July 23, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first

Andra AP fonden lifted its position in shares of Insmed, Inc. (NASDAQ: INSM) by 114.8% in the first

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.b

Wall Street analysts are making bold moves on Tuesday, shaking up ratings for some of the biggest na

BMO Capital analyst Connor Mackay initiates coverage on Insmed (NASDAQ:INSM) with a Outperform ra

Stanley Druckenmiller doesn't do consensus. The Duquesne Family Office's latest 13F reveals a top-fi

Insmed reports 12-month TPIP extension data showing sustained efficacy and favorable safety in PAH a

–12-Month Data Demonstrated Sustained Improvement with TPIP Across All Secondary Efficacy Measures I

Wells Fargo analyst Benjamin Burnett maintains Insmed (NASDAQ:INSM) with a Overweight and raises

Evercore ISI Group analyst Josh Schimmer maintains Insmed (NASDAQ:INSM) with a Outperform and low

Nebius Group N.V. (NASDAQ: NBIS) stock surged on Tuesday after confirming its upcoming addition to t

CoreWeave, Astera Labs, Nebius, Rocket Lab & Teradyne join the Nasdaq-100. Jim Cramer calls this

CRWV stock climbs 5% as CoreWeave gears up to join the Nasdaq-100. Get the latest price action, incl

Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts OR

Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analys

JP Morgan analyst Jessica Fye maintains Insmed (NASDAQ:INSM) with a Overweight and lowers the pri

RBC Capital analyst Leonid Timashev maintains Insmed (NASDAQ:INSM) with a Outperform and lowers t

Common StockDebt SecuritiesWe or any selling securityholder may from time to time offer to sell the